Bartosz Skóra

943 total citations
55 papers, 697 citations indexed

About

Bartosz Skóra is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Bartosz Skóra has authored 55 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Biochemistry. Recurrent topics in Bartosz Skóra's work include Peroxisome Proliferator-Activated Receptors (9 papers), Nanoparticles: synthesis and applications (7 papers) and Synthesis and biological activity (6 papers). Bartosz Skóra is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (9 papers), Nanoparticles: synthesis and applications (7 papers) and Synthesis and biological activity (6 papers). Bartosz Skóra collaborates with scholars based in Poland, Ukraine and United States. Bartosz Skóra's co-authors include Konrad A. Szychowski, Tomasz Piechowiak, Jan Gmiński, Maciej Balawejder, Katarzyna Grzelak-Błaszczyk, Michał Sójka, Małgorzata Kus‐Liśkiewicz, Andrzej Dziedzic, Anna K. Wójtowicz and Kamila Rybczyńska‐Tkaczyk and has published in prestigious journals such as Scientific Reports, Food Chemistry and Chemosphere.

In The Last Decade

Bartosz Skóra

51 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bartosz Skóra Poland 15 208 136 124 96 93 55 697
Melanie Esselen Germany 17 294 1.4× 150 1.1× 134 1.1× 91 0.9× 56 0.6× 50 845
Ömer Hazman Türkiye 18 205 1.0× 125 0.9× 165 1.3× 58 0.6× 50 0.5× 60 914
Ionel Fizeșan Romania 17 163 0.8× 74 0.5× 149 1.2× 115 1.2× 51 0.5× 40 782
Başak Toğar Türkiye 19 194 0.9× 69 0.5× 281 2.3× 100 1.0× 70 0.8× 41 864
Nadia Z. Shaban Egypt 16 173 0.8× 53 0.4× 127 1.0× 72 0.8× 55 0.6× 39 734
Ganesan Muthusamy India 19 347 1.7× 105 0.8× 103 0.8× 58 0.6× 39 0.4× 32 984
Debasree Ghosh India 14 177 0.9× 120 0.9× 62 0.5× 117 1.2× 39 0.4× 36 743
Mohammed Al‐Zharani Saudi Arabia 17 328 1.6× 94 0.7× 202 1.6× 85 0.9× 69 0.7× 108 1.1k
Feng-Lin Yen Taiwan 13 282 1.4× 96 0.7× 188 1.5× 52 0.5× 72 0.8× 16 1.2k
Ming‐Kuei Shih Taiwan 19 278 1.3× 56 0.4× 99 0.8× 60 0.6× 52 0.6× 54 878

Countries citing papers authored by Bartosz Skóra

Since Specialization
Citations

This map shows the geographic impact of Bartosz Skóra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bartosz Skóra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bartosz Skóra more than expected).

Fields of papers citing papers by Bartosz Skóra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bartosz Skóra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bartosz Skóra. The network helps show where Bartosz Skóra may publish in the future.

Co-authorship network of co-authors of Bartosz Skóra

This figure shows the co-authorship network connecting the top 25 collaborators of Bartosz Skóra. A scholar is included among the top collaborators of Bartosz Skóra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bartosz Skóra. Bartosz Skóra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skóra, Bartosz, et al.. (2025). Impact of Hericium erinaceus and Ganoderma lucidum metabolites on AhR activation in neuronal HT-22 cells. Pharmacological Reports. 77(6). 1557–1572.
3.
Kukuła‐Koch, Wirginia, Krzysztof Jóźwiak, Małgorzata Anna Marć, et al.. (2025). Biotransformation of Ganoderma lucidum and Hericium erinaceus for ex vivo gut-brain axis modulation and mood-related outcomes in humans: CREB/BDNF signaling and microbiota-driven synergies. Journal of Ethnopharmacology. 342. 119393–119393. 2 indexed citations
4.
Skóra, Bartosz, Tomasz Piechowiak, & Konrad A. Szychowski. (2024). Engagement of specific intracellular pathways in the inflammation-based reprotoxicity effect of small-size silver nanoparticles on spermatogonia and spermatocytes in vitro cell models. Chemosphere. 363. 142897–142897. 8 indexed citations
5.
Skóra, Bartosz, et al.. (2024). Role of 4-Thiazolidinone–Pyrazoline/Indoline Hybrids Les-4369 and Les-3467 in BJ and A549 Cell Lines. Cells. 13(12). 1007–1007. 2 indexed citations
7.
Szychowski, Konrad A. & Bartosz Skóra. (2024). Elastin-derived peptides (EDPs) as a potential pro-malignancy factor in human leukemia cell lines. Immunologic Research. 72(5). 1092–1107. 1 indexed citations
8.
Olender, Dorota, et al.. (2023). Curcuminoid Chalcones: Synthesis and Biological Activity against theHuman Colon Carcinoma (Caco-2) Cell Line. Current Medicinal Chemistry. 31(33). 5397–5416. 4 indexed citations
10.
Skóra, Bartosz, et al.. (2023). Reprotoxic Effect of Tris(2,3-Dibromopropyl) Isocyanurate (TBC) on Spermatogenic Cells In Vitro. Molecules. 28(5). 2337–2337. 6 indexed citations
11.
Szychowski, Konrad A. & Bartosz Skóra. (2023). Involvement of the aryl hydrocarbon receptor (AhR) in the mechanism of action of elastin-derived peptide (VGVAPG) and its impact on neurosteroidogenesis. Neurochemistry International. 171. 105615–105615. 4 indexed citations
12.
Rybczyńska‐Tkaczyk, Kamila, Bartosz Skóra, & Konrad A. Szychowski. (2023). Toxicity of bisphenol A (BPA) and its derivatives in divers biological models with the assessment of molecular mechanisms of toxicity. Environmental Science and Pollution Research. 30(30). 75126–75140. 29 indexed citations
13.
Skóra, Bartosz, Anna Lewińska, Anna Kryshchyshyn‐Dylevych, et al.. (2022). Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives. Molecules. 27(3). 894–894. 27 indexed citations
14.
Szychowski, Konrad A., Bartosz Skóra, Anna Kryshchyshyn‐Dylevych, et al.. (2021). 4-Thiazolidinone-based derivatives do not affect differentiation of mouse embryo fibroblasts (3T3-L1 cell line) into adipocytes. Chemico-Biological Interactions. 345. 109538–109538. 10 indexed citations
16.
Skóra, Bartosz, Tomasz Piechowiak, Konrad A. Szychowski, & Jan Gmiński. (2021). Entrapment of silver nanoparticles in L-α-phosphatidylcholine/cholesterol-based liposomes mitigates the oxidative stress in human keratinocyte (HaCaT) cells. European Journal of Pharmaceutics and Biopharmaceutics. 166. 163–174. 22 indexed citations
18.
Szychowski, Konrad A., Bartosz Skóra, Anna Kryshchyshyn‐Dylevych, et al.. (2020). Induction of Cyp450 enzymes by 4-thiazolidinone-based derivatives in 3T3-L1 cells in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(5). 915–927. 11 indexed citations
19.
Szychowski, Konrad A., et al.. (2020). Elastin-derived peptide VGVAPG decreases differentiation of mouse embryo fibroblast (3T3-L1) cells into adipocytes. Adipocyte. 9(1). 234–245. 12 indexed citations
20.
Szychowski, Konrad A., et al.. (2020). Inonotus obliquus – from folk medicine to clinical use. Journal of Traditional and Complementary Medicine. 11(4). 293–302. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026